Generics controversy issue widens

Jun 05, 2006

A dispute between the U.S. Justice Department and Federal Trade Commission over generic drugs is reportedly widening with implications for the drug firms.

The issue relates to the legality of deals between drug companies and those making the generic versions, reports the Financial Times. As the controversy heats up, the FTC, over the objections of the Bush administration, may file a second petition urging the Supreme Court to decide the issue.

The Financial Times report says the rift between the two departments results from a complex patent dispute involving a company and a drug for treating the side effects of blood pressure medicines. The FTC claims a deal the company and a generic rival made subsequently is anti-competitive.

The report says while settlements between drug companies do not usually violate antitrust laws, they do when branded drug groups offer their generic rivals deals to stay out of the market until a certain date.

Copyright 2006 by United Press International

Explore further: Researchers discover low-grade nonwoven cotton picks up 50 times own weight of oil

add to favorites email to friend print save as pdf

Related Stories

X-ray imaging reveals a complex core

Jul 04, 2014

Macromolecular complexes composed of self-assembling proteins and nucleic acids hold promise for a wide range of applications, including drug delivery, sensing and molecular electronics. Scientists have developed ...

Materials scientists turn to collagen

Jun 05, 2014

(Phys.org) —Miniature scaffolds made from collagen – the 'glue' that holds our bodies together – are being used to heal damaged joints, and could be used to develop new cancer therapies or help repair ...

Recommended for you

Research looks to combat US Latina immigrant obesity

1 hour ago

According to the U.S. Census Bureau, Latinos are the largest minority group in the United States, comprising 16.7% of the population. Approximately one-third of Latinos are obese and are 1.2 times as likely to be obese compared ...

User comments : 0